A critical advance in cancer study is arising with the use of mini-antibodies to reactivate damaged p53. This vital tumor inhibitor protein is frequently disabled in various types of malignancies, causing uncontrolled https://enrollbookmarks.com/story21878323/vhh-fragments-restore-p53-a-potential-approach-for-malignant-therapy